Karen Tubridy

2016

In 2016, Karen Tubridy earned a total compensation of $582.3K as Former Chief Development Office at Eleven Biotherapeutics, a 37% decrease compared to previous year.

Compensation breakdown

Option Awards$24,652
Salary$233,889
Other$323,710
Total$582,251

Tubridy received $323.7K in other compensation, accounting for 56% of the total pay in 2016.

Tubridy also received $24.7K in option awards and $233.9K in salary.

Rankings

In 2016, Karen Tubridy's compensation ranked 10,640th out of 14,075 executives tracked by ExecPay. In other words, Tubridy earned more than 24.4% of executives.

ClassificationRankingPercentile
All
10,640
out of 14,075
24th
Division
Manufacturing
4,125
out of 5,489
25th
Major group
Chemicals And Allied Products
1,462
out of 1,895
23rd
Industry group
Drugs
1,174
out of 1,538
24th
Industry
Pharmaceutical Preparations
918
out of 1,176
22nd
Source: SEC filing on April 7, 2017.

Tubridy's colleagues

We found four more compensation records of executives who worked with Karen Tubridy at Eleven Biotherapeutics in 2016.

2016

Abbie Celniker

Eleven Biotherapeutics

Chief Executive Officer

2016

Stephen Hurly

Eleven Biotherapeutics

Chief Executive Officer

2016

John McCabe

Eleven Biotherapeutics

Chief Financial Officer

2016

Arthur DeCillis

Eleven Biotherapeutics

Chief Medical Officer

You may also like